Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis
Despite multiple possible oncogenic mutations in the proto-oncogene KRAS, unique subsets of these mutations are detected in different cancer types. As KRAS mutations occur early, if not being the initiating event, these mutational biases are ostensibly a product of how normal cells respond to the en...
Main Authors: | Özgün Le Roux, Nicole LK Pershing, Erin Kaltenbrun, Nicole J Newman, Jeffrey I Everitt, Elisa Baldelli, Mariaelena Pierobon, Emanuel F Petricoin, Christopher M Counter |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/75715 |
Similar Items
-
p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
by: Özgün Le Roux, et al.
Published: (2024-01-01) -
O PROTO-ONCOGENE RAS NO BÓCIO MULTINODULAR
by: Lenara Golbert, et al.
Published: (2022-07-01) -
Patterning of oncogenic Ras clustering in live cells using vertically aligned nanostructure arrays
by: Mu, Huanwen, et al.
Published: (2022) -
Cooperation of hTERT, SV40 T Antigen and Oncogenic Ras in Tumorigenesis: A Cell Transplantation Model Using Bovine Adrenocortical Cells
by: Michael Thomas, et al.
Published: (2002-01-01) -
The current understanding of KRAS protein structure and dynamics
by: Tatu Pantsar
Published: (2020-01-01)